Australian Clinical Labs Limited (ASX: ACL) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Australian Clinical Labs Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Australian Clinical Labs Limited (ASX: ACL)
Latest News
52-Week Lows
3 ASX 300 shares hitting new 52-week lows: Are they cheap buys?
Share Market News
These are the 10 most shorted ASX shares
Share Market News
These are the 10 most shorted ASX shares
Share Market News
These are the 10 most shorted ASX shares
Dividend Investing
Popular ASX All Ords shares with ex-dividend dates next week
How to invest
Shares vs. property: Why cheaper homes and ASX small-cap shares are rising fastest in 2024
Earnings Results
2 ASX 300 shares crashing up to 12% on earnings updates
Healthcare Shares
2 ASX healthcare shares with 'compelling' valuations to buy
Small Cap Shares
3 'attractive' small-cap ASX shares ready to rocket in 2024
Share Fallers
Why Australian Clinical Labs, Meridian, MyState, and Sigma shares are falling today
Healthcare Shares
This ASX healthcare share just hit a 52-week low, is it time to buy?
Broker Notes
2 ASX shares that could EXPLODE when their M&A deals are done
Frequently Asked Questions
-
Yes, Australian Clinical Labs has historically paid two fully franked shareholder dividends a year.
-
Australian Clinical Labs generally pays its shareholder dividends in April and September.
-
Australian Clinical Labs Ltd listed on the ASX on 14 May 2021.
ACL ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Australian Clinical Labs Limited
Australian Clinical Labs Ltd (ASX: ACL) is a leading provider of pathology services in Australia. The company's 75 laboratories perform more than 12 million episodes annually with a network of more than 1,300 collection centres in every Australian state and territory except Tasmania. The company is also among the largest private hospital pathology businesses in the country, providing services to more than 90 private and public hospitals.
Its services include all routine pathology tests, advanced pathology, pregnancy screening, non-invasive prenatal testing, chemical pathology, haematology, histopathology, immunology, serology and microbiology, and commercial drug and alcohol testing.
In ACL's established regions of Western Australia, Victoria, New South Wales, Queensland, South Australia, and the Northern Territory, the company has an equivalent market position in community pathology to its rivals Sonic Healthcare Ltd (ASX: SHL) and Healius Ltd (ASX: HLS). The company says it also has a growing presence in the Australian Capital Territory.